David Potter to Cyclic GMP
This is a "connection" page, showing publications David Potter has written about Cyclic GMP.
Connection Strength
0.276
-
Moxonidine-induced inhibition of norepinephrine release in monkey and rabbit ciliary bodies: role of cGMP. Pharmacology. 1997 Oct; 55(4):211-6.
Score: 0.138
-
Naphazoline-induced neuroendocrine changes: increases in ANP and cGMP levels, but suppression of NE, 3H-NE, and cAMP levels in rabbit eyes. Pharmacology. 2002 Jul; 65(3):155-61.
Score: 0.048
-
Functional identification of phosphodiesterase activity in human trabecular meshwork cells. J Ocul Pharmacol Ther. 2000 Aug; 16(4):317-22.
Score: 0.042
-
Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 1999 Jul; 40(8):1745-52.
Score: 0.039
-
Effects of adrenergic drugs on aqueous cAMP and cGMP and intraocular pressure. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1979; 212(2):65-75.
Score: 0.009